Showing results (11-20 of 402) with videos related to
Sort By:
Pageof 41
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicineHiddo J Lambers Heerspink, Rainer Oberbauer, Paul Perco, et al.Molecular Biosystems|September 28, 2012
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profilesJohannes Söllner, Paul Mayer, Andreas Heinzel, et al.BMC Medical Genomics|December 26, 2014
A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseasesHannes Neuwirt, Paul Perco, Alexander Kainz, et al.Wiener Medizinische Wochenschrift (1946)|August 5, 2008
An update on the relationship between the kidney, salt and hypertensionGert MayerAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2002
ACE genotype and ACE inhibitor response in kidney disease: a perspectiveGert MayerNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2011
Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal diseaseGert MayerTransplantation|April 25, 2007
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft functionAlexander Kainz, Paul Perco, Bernd Mayer, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|January 6, 2004
Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft functionPeter Hauser, Christoph Schwarz, Christa Mitterbauer, et al.Proteomics. Clinical Applications|April 15, 2011
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathyRaul Fechete, Andreas Heinzel, Paul Perco, et al.Diabetologia|July 5, 2016
Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbiditiesBernd MayerPageof 41